Metagenomic Sequencing Market Growth and Forecast Report 2030

1
Metagenomic Sequencing Industry Growth and
Forecast Report 2030
2
The value of the metagenomic sequencing market
was USD 1,938 million in 2022, which will grow at
a rate of 17.20 during the forecast period,
touching, USD 6,899 million by 2030. Drug
discovery had the largest share of revenue of
over 26, in 2022, and it will continue like this
in the years to come as well. This is due to the
increasing research in the pharma and biotech
industries for new drug discovery, frequently as
part of partnerships amongst the stalwarts of the
market and academic institutes. The clinical
diagnostics will grow the fastest by the end of
this decade, because of the making of tools and
software for genomic research and increasing
occurrence of infectious ailments.
3
The shotgun technique dominated the industry. It
will continue like this in the future as well, as
a result of the advantages presented by this
process and the increase in the count of
genomic-based research actions directed by
research and academic institutes. Additionally,
the whole-genome sequencing will grow
significantly in the future. Companies are trying
for the expansion expand of their product
portfolios presented for the diagnosis of the not
so common diseases. Furthermore, researchers are
quickly accepting this method because of its
authorization in DNA profiling. Download sample
pages of this report https//www.psmarketresearch
.com/market-analysis/metagenomic-sequencing-market
/report-sample The sequencing category had the
largest share in the metagenomic sequencing
market, and it will continue its dominance in the
years to come, told by an expert at PS
Intelligence.
4
Sequencing techniques are often used by
healthcare organizations and researchers for
genetic studies, crucial component of genetic
testing. The cost of sequence modeling has
decreased by about 28 yearly because of tech
advancements, which will power its
acceptance. Data processing analysis will grow
significantly because of the rising intricacies
in upholding the read data of billions of
sequences. North America had the largest share,
of over 42, in 2022, and it will power at a
significant rate in the years to come. This will
be credited to the considerable RD activities in
the pharma and biotech sectors, increased the
risk of diseases, presence of trustworthy
healthcare businesses, and support for the
initiation of new RD facilities.
5
Furthermore, Europe is growing considerably in
the acceptance of this technology as a result of
the incidence of prominent market participants.
As well, the partnerships between government
organizations and the sequencing solution
providers are accountable for the advance of the
industry. It is also thriving because of the
obtainability of cutting-edge genomic sequencing
technology. Due to the increasing incidence of
genetic and infectious disease, the demand for
metagenomic sequencing systems will grow even
more by the end of this decade. Read more
https//www.psmarketresearch.com/market-analysis/m
etagenomic-sequencing-market
6
Disclaimer PS Intelligence always keeps its
customers interests at the core while carrying
out research activities. PS Intelligence ensures
the reliability and accuracy of information and
data provided in its market research
publications. However, the information in
publications is subject to fluctuations, as it is
based on primary interviews of officials from
various companies or organizations. PS
Intelligence is not responsible for any incorrect
data provided by the key industry players of the
concerned domain. the information or analysis in
PS Intelligence publications represents opinions
based on research and should not be interpreted
as statements of fact. Information in this report
was believed to be correct at the time of
publication, but cannot be guaranteed. PS
Intelligence does not endorse any product,
service, or vendor depicted in its research
publications. All intellectual properties,
including trademarks and copyrights, belong to
their respective owners and may be protected by
copyright. Under no circumstance can these be
reproduced in any form without prior written
agreement of their owners. An order for market
research report is intended for internal use of
the company only and not for disclosure to third
parties or any other publication in general. No
service, report, or part thereof provided by PS
Intelligence can be reproduced, republished,
resold, revealed, distributed, circulated, or
sublicensed in any medium or form now realized or
hereafter become realized, including but not
limited to, all forms of optical-based media,
magnetic, electronic, or digital, without a
written permission from Prescient Strategic
Intelligence Pvt. Ltd.